This page shows the latest Rebinyn news and features for those working in and with pharma, biotech and healthcare.
Plans to launch the haemophilia B treatment in the fourth quarter
launch Rebinyn (nonacog beta pegol or N9-GP) in the US until the first half of next year. ... We are confident that Rebinyn will become an important tool for physicians to help patients manage their bleeds.".
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....